This is the authors' abstract. We don't add key points for this paper.
A series of new molecules having 3-(substituted)-4,5,6,7-tetrahydro-6-(substituted)-1 H -pyrazolo[3,4- c ]pyridine and 3-(substituted)-5,6-dihydro-6-(substituted)-1 H -pyrazolo[3,4- c ] pyridin-7(4 H )-one derivatives were designed and synthesized in large scale (grams range). The structures of the synthesized compounds were elucidated and confirmed by 1 H NMR, 13 C NMR, Mass spectra; and purity was also checked through LC/MS and HPLC analysis. The antiproliferative activity of the compounds was checked for lung cancer, cervical cancer, breast cancer and prostate cancer on panel of four cell lines. A few compounds (13c, 13g, 15g and 15h) showed promising antiproliferative activity in the range of 5.12-17.12 µM which were further tested for their inhibitory activity against panel of 8 human kinases at 10 µM concentrations. The compounds 13c, 13g, 15g and 15h shows prominent inhibitory activity against Aurora-A, Aurora-B, CDK 5 /P 25 and mTOR kinases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pawar et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: